This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb. Active years: 2000-2026.
Location History:
- Hamilton Township, NJ (US) (2000)
- Pennington, NJ (US) (2006 - 2008)
Company Filing History:
Years Active: 2000-2026
Title: Nathan O Siemers: Innovator in Human Phosphatase Research
Introduction
Nathan O Siemers is a prominent inventor based in Hamilton Township, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of human phosphatases. With a total of 5 patents to his name, Siemers has focused on developing novel polynucleotides and their applications in diagnosing and treating various diseases.
Latest Patents
Siemers' latest patents include groundbreaking work on human phosphatase RET31 and its variants. The inventions provide novel polynucleotides encoding human phosphatase polypeptides, fragments, and homologues. Additionally, the patents cover vectors, host cells, antibodies, and methods for producing these polypeptides. The inventions also relate to diagnostic and therapeutic methods for applying these polypeptides to the diagnosis, treatment, and prevention of diseases, particularly cardiovascular disorders. Furthermore, the patents include screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides.
Career Highlights
Throughout his career, Nathan O Siemers has worked with notable companies, including Bristol-Myers Squibb Company. His experience in the pharmaceutical industry has allowed him to contribute to significant advancements in medical research and biotechnology.
Collaborations
Siemers has collaborated with esteemed colleagues such as Liana M Lee and John N Feder. These partnerships have further enhanced his research and development efforts in the field of human phosphatases.
Conclusion
Nathan O Siemers is a distinguished inventor whose work in human phosphatase research has the potential to impact the diagnosis and treatment of various diseases. His innovative contributions continue to advance the field of biotechnology and improve healthcare outcomes.